Who Should I Sell My Veterinary Practice To? A 2026 Buyer-Type Guide

Key takeaways

• There are 3 buyer types for a veterinary practice in 2026: private equity-backed groups, strategic buyers, and individual veterinarians or small regional groups. Each is a legitimate, well-funded path.
• No single buyer type is best for everyone. The right one depends on what you optimize for: price, what happens to your staff, whether the practice keeps its name, how much cash you take at close, and what role you want afterward.
• PE-backed groups and large strategic buyers generally pay the highest headline numbers for practices that fit their target profile. Individual buyers often fit smaller practices, single-successor handoffs, and owners who value a clean local transition.
• Mars Veterinary Health is the strategic exception in this market, family-owned by Mars, Incorporated, and the only major buyer that is not private equity-backed.
• A competitive process reveals the best fit and the best price across all three categories at once, which matters more to your outcome than picking a category in the abstract.

There’s a question I get asked more than almost any other, usually somewhere in the first hour of getting to know a vet over dinner. It isn’t “what’s my practice worth.” It’s quieter than that, and it comes out once the owner trusts me a little. Who should I even sell this to?

It’s a better question than the valuation one, honestly. Because the owner asking it has already figured out something it takes most people a while to see.

The kind of buyer you sell to shapes the rest of your professional life, and the lives of the people who work for you, almost as much as the number on the check does.

So this guide is the answer to that question. There are three kinds of buyers for a veterinary practice in 2026, and I want to walk you through all three the way I’d walk you through them in person.

What each one generally pays. What each one tends to mean for your team, your practice’s name, and your own role after closing.

And, most important, which kind of owner each one actually fits. Not the press-release version of any of them.

The honest one.

In 2026, a veterinary practice owner has 3 types of buyers to choose from: private equity-backed groups, strategic buyers, and individual veterinarians or small regional groups. Each is a viable, well-capitalized path, and none is universally “best.” The right buyer for you depends on what you’re optimizing for, including price, what happens to your staff, whether the practice keeps its name, how much of the money you take as cash at close, and what role you want after the sale.

The single most reliable way to find the best fit and the best price is to run a competitive process that puts qualified buyers from more than one category in front of your practice at the same time, and lets them compete.

The three buyer types, side by side

Before I take each buyer type apart, here’s the whole landscape on one table. I’d sketch something close to this on a legal pad for any owner trying to get their bearings.

The pay column is directional and industry-wide. It describes the general pattern across each category, not what any one named buyer pays, and not what your practice specifically would clear.

Where your number actually lands depends on your practice and, more than anything, on whether the buyers know they’re competing.

Buyer type	What they generally pay (directional)	Your staff and branding	Deal structure	Best for
PE-backed group	Highest headline multiples for practices that fit the target profile, especially $1M-plus EBITDA. Pays for scale and future growth.	Generally keeps the local name and team; the local brand is part of what they buy. Day-to-day clinical decisions usually stay with the medical team.	Majority cash at close, with the rest commonly split among earnout, rollover equity, or a partnership stake to keep you invested.	Larger, multi-doctor practices; owners who want a strong price and are open to keeping some skin in the game.
Strategic buyer	Competitive, often top-of-market for practices in priority locations. Buys to operate long term, not to resell.	Mars-owned brands have historically moved acquired practices onto national branding over time more than PE-backed groups do. Team generally retained.	Typically a mostly-cash purchase. Long-term operator, so less reliance on seller rollover.	Owners in markets a large operator wants, who value a deep-pocketed, permanent home for the practice.
Individual / regional buyer	Lower headline numbers, constrained by financing, but sometimes simpler terms and high cash at close.	Almost always keeps the name, team, and culture; they’re buying a working practice to run themselves.	SBA or conventional financing; often a seller note and a defined transition period.	Smaller practices; owners who want a single local successor to mentor and a clean community handoff.

One thing to notice before we go deeper. The “best for” column is about the owner, not the practice.

Two owners with nearly identical practices can correctly choose two different buyer types, because they want different things out of the sale.

That’s the whole point of this guide. The “best” buyer is the one whose strengths line up with what you actually care about.

Buyer type 1: The private equity-backed group

Let me start with the buyer most owners think of first, and the one most owners misunderstand first.

A PE-backed group is a veterinary group whose growth is funded by a private equity firm. The firm buys practices, brings them under shared services like billing, HR, marketing, and purchasing, and aims to sell the combined platform at a higher value in roughly 3 to 7 years.

That holding horizon is the key to understanding everything they do. They’re not buying your practice to run it forever.

They’re buying it to make the larger group more valuable, then to sell that larger group.

What they generally pay

This is the category that pays the highest headline numbers, and there’s a clean economic reason why. A PE-backed group isn’t just buying your earnings.

It’s buying earnings it can fold into a bigger platform that trades at a higher multiple than your standalone practice ever could.

That mechanism, buying smaller practices and combining them into something worth more per dollar of earnings, lets them justify paying you more than an individual buyer can. Per AAHA’s reporting on consolidation in the profession, private equity became the most active acquiring force in veterinary medicine over the last several years for exactly this reason.

The strongest pay generally goes to practices producing about $1 million or more in normalized EBITDA, with multiple doctors and real management depth. For the full picture of what these buyers pay and how the money is structured, I’ve written a dedicated guide on how much private equity is paying for veterinary practices.

What it means for your staff and your name

Here’s where I have to correct the single most common fear I hear. Owners worry that a PE-backed sale means a rebrand and a gutting of the team.

In 2026, that’s mostly not how it works.

Most PE-backed groups today generally preserve the local practice name, keep the existing team, and leave day-to-day clinical decisions with the medical staff. The reason is simple economics.

Your local reputation, your clients’ loyalty to your name, your doctors and technicians: those are part of what they paid for. Tearing them out destroys the value they just bought.

Deal structure and your role

A PE-backed offer is almost never all cash on closing day. The typical structure pays the majority as cash at close and splits the rest among an earnout, rollover equity, or a partnership stake.

Rollover equity means keeping a slice of ownership in the new entity after the sale instead of taking all cash, so you participate when the firm sells the platform later. A growing number of these deals use a partnership or joint venture structure, where the buyer takes a majority of the practice and you keep a minority stake with a defined buyout at a future date.

Per MB Law Firm’s 2025 commentary on healthcare deal trends, that partnership model has become increasingly common.

These buyers usually want you to stay on for a transition, often a few years, and the rollover or partnership stake is designed to keep you motivated through it. The terms are negotiable, which is exactly why the process you run matters.

This buyer fits you if: your practice is sizable and multi-doctor, you want a strong price, and you’re comfortable keeping some economic stake and staying involved through a transition.

Buyer type 2: The strategic buyer

The second category is the one people most often lump in with the first, and it’s a real mistake to do so.

A strategic buyer acquires practices to operate them long term inside a larger company, not to resell the platform in a few years. Their return comes from running the practices well at scale, not from a future sale of the group.

In veterinary medicine, the defining strategic buyer is Mars Veterinary Health. And Mars is genuinely different, which is why I always name it as the exception.

Why Mars is the strategic exception

Mars Veterinary Health is family-owned, by Mars, Incorporated, the company the descendants of founder Frank Mars still control. As Fortune reported in its profile of the operation, Mars is the largest provider of veterinary care in the country, and unlike a private equity firm, it tends to hold what it buys for the long term rather than reselling on a fund timeline.

Its veterinary brands are ones you already know: Banfield Pet Hospital, VCA Animal Hospitals, and BluePearl on the specialty and emergency side. When people in this profession say “the strategic buyer,” Mars is almost always who they mean.

What it means for your staff and your name

This is the one category where the branding question deserves real attention, and I’ll give it to you straight because the buyer-relations rule cuts both ways: I won’t disparage Mars, and I won’t pretend the pattern doesn’t exist.

Historically, Mars-owned brands have moved more acquired practices onto national branding over time than most PE-backed groups do. For some owners that’s a genuine positive.

A nationally recognized name, a deep-pocketed permanent parent, and the resources of one of the largest private companies in the world can be exactly what an owner wants for the practice they’re leaving behind.

For an owner whose top priority is that the practice keeps the name on the sign for the next 30 years, it’s a point to weigh and to raise directly in negotiation.

What they generally pay, and your role

Strategic buyers can be very competitive on price, often at the top of the market, for practices in locations they specifically want to grow. Because they’re long-term operators rather than resellers, their offers typically lean toward a mostly-cash structure with less reliance on seller rollover than the PE-backed model.

Per Capstone Partners‘ April 2026 Pet Sector M&A Update, strategic buyer activity in the pet sector jumped to 10 transactions in the first months of 2026, up from just 3 in the same window a year earlier, so this is an active and growing part of the buyer pool, not a sleepy one.

This buyer fits you if: your practice sits in a market a large operator is targeting, you value a permanent and deeply capitalized home for the practice, and you’re comfortable with the possibility of eventual national branding.

Buyer type 3: The individual veterinarian or regional group

The third category is the oldest one, the way practices changed hands for generations before any group existed. And it is very much still alive.

An individual buyer is a practicing veterinarian, or a small regional group of a few veterinarians, buying a practice to own and run it directly. They’re usually financed through an SBA loan or a conventional practice loan rather than a fund’s capital.

There’s good evidence this segment is reasserting itself. A 2025 peer-reviewed analysis in Frontiers in Veterinary Science made the case for a resurgent independent practice segment in the United States, and the AVMA and groups like VetPartners have explicitly worked to keep individual ownership a viable path by demystifying the financing.

What they generally pay

Here’s the honest tradeoff. Individual buyers usually can’t match the headline multiples of the institutional buyers, and the reason isn’t that they value your practice less.

It’s that they’re constrained by what a lender will finance.

An associate buying her first practice, or an established owner adding a second location, is borrowing against the practice’s cash flow. SBA and conventional veterinary lending have practical ceilings, and those ceilings generally cap what an individual can pay.

The institutional buyers, by contrast, can pay more because they extract efficiencies across a platform that an individual simply doesn’t have.

So if your practice produces well over $1 million in EBITDA, the math often means an individual buyer can’t be the top bidder. On smaller practices, individuals are frequently right in the mix, and sometimes the best fit by a wide margin.

What it means for your staff, your name, and your legacy

This is the category that scores highest on continuity, almost by definition. An individual buyer is purchasing an established, working practice, including its name, its team, and its place in the community.

They have every incentive to keep all of it intact, because that continuity is what they’re betting their career and their loan on.

For a lot of owners, that’s the emotional center of the whole decision. If what keeps you up at night is whether your staff stays employed and whether the practice you built still feels like itself in five years, an individual successor is often the most natural answer.

Deal structure and your role

These deals tend to be simpler. Often a mostly-cash purchase funded by the buyer’s financing, sometimes with a seller note, where you finance part of the price and get paid back over time, and usually a defined transition period while you hand off relationships.

The role you play afterward is frequently the warmest of the three. Many of these sales are mentorships as much as transactions, an established owner bringing along the next generation of one specific doctor.

This buyer fits you if: your practice is on the smaller side, you want a single local successor you can mentor, and a clean handoff that protects your team and your name matters to you more than squeezing out the last dollar of headline price.

So which buyer is actually “best”?

Now the question underneath the question. Having seen all three, which should you pick?

My honest answer, and I’ve watched this play out enough times that I’ve stopped hedging on it, is that the category isn’t the decision. What you’re optimizing for is the decision.

The category just follows from that.

Walk through your own priorities in roughly this order, and the answer tends to reveal itself.

If your top priority is price, and your practice is large enough to interest them, the institutional buyers, PE-backed groups and large strategic buyers, generally set the ceiling. That’s just where the most capital and the strongest economic model sit.

If your top priority is your staff and your legacy, weight toward the buyer most structurally committed to keeping them, which is often an individual successor, though many PE-backed groups now preserve teams and local names well too.

If your top priority is a clean exit, screen every buyer in every category against the length and intensity of transition they’ll accept, because that varies more by the specific buyer than by the category.

If your top priority is certainty of the money, weight toward the structures with the most cash at close and the least contingent consideration, which often means strategic and individual buyers, though a well-negotiated PE-backed deal can get you most of the way there.

Most owners, when they’re honest, care about several of these at once. That’s normal.

It’s also exactly why the abstract question, “which category is best,” has no clean answer in a vacuum, and why the right next step isn’t to pick a category at all.

The move that beats picking a category: make them compete

Here’s the part I most want you to take from this guide. You don’t actually have to choose a buyer category up front, sight unseen, based on a table on a legal pad.

The better move is to put qualified buyers from more than one category in front of your practice at the same time, under the same information and the same timeline, and let them show you what they’ll really do. That structure answers two questions at once.

It reveals which category genuinely fits your goals, and it produces the best price within that fit, because every buyer at the table knows they’re competing.

That’s the work we do, and we call it the Elite Selling System. The name describes how it actually runs.

We hand-select and vet every buyer who gets to bid on your practice, the way a doorman with a velvet rope lets in only the right people, then we run a private competitive window inside that vetted group.

The effect on behavior is dramatic, and it’s the same for every category. A buyer who knows they’re the only one in the room offers their most comfortable number.

The same buyer, knowing a qualified competitor is one phone call from outbidding them, calibrates to the market instead. That isn’t anybody behaving badly.

It’s every rational buyer responding to leverage, which is precisely what a structured process creates and a quiet one-on-one conversation destroys.

And it surfaces fit you’d never see otherwise. I’ve watched owners walk in certain they wanted to sell to one type of buyer, and then a buyer from a different category turned out to fit their priorities, and their number, far better once everyone was actually competing on the same terms.

You don’t find that out by guessing. You find it out by running the process.

For the mechanics of how that process runs end to end, see our guide on selling a veterinary practice. For the broader question of how to sell once you’ve decided to, see sell my veterinary practice.

A pattern from our deal flow

I’ll give you the shape of something I see constantly, framed as the general pattern it is rather than any one identifiable deal.

An owner comes in convinced they already know who their buyer is. Sometimes it’s an associate they’ve been quietly grooming.

Sometimes it’s a particular group whose acquisition person has been calling for a year. They’re not wrong that the buyer is a fit.

They’re just working with one data point.

When we open that same practice to a properly vetted group of buyers across categories, two things tend to happen. The buyer the owner already liked usually steps up their terms once they know they’re not alone.

And often a buyer the owner hadn’t seriously considered, from a different category entirely, comes in with a combination of price, structure, and transition that fits the owner’s actual priorities better than the original favorite did.

Across the deals we’ve closed over the past four-plus years, the average outcome has landed well above what a single direct offer typically produces, often by several multiples of EBITDA on the headline. Same practice.

Same buyers, in some cases. The difference was running a real process across the whole buyer landscape instead of negotiating with one corner of it.

What’s actually happening in the 2026 buyer market

A little market context, because it shapes who’s at the table right now.

The buyer pool is active and getting more so. Capstone Partners‘ April 2026 Pet Sector M&A Update counted 18 announced or completed pet-sector transactions in the first months of 2026, more than double the 8 in the same window of 2025, with the Vet & Health segment accounting for 9 of them, the largest single share.

Both the institutional categories are leaning in. As noted above, strategic buyer activity tripled year over year per that same Capstone update.

And on the private equity side, Capstone expects financial-sponsor activity to strengthen further through 2026 and 2027, as the firms behind these groups face pressure from their own investors to return cash, which usually means more buying and, eventually, more selling of platforms.

The regulatory backdrop is busier than it was a few years ago too. Holland & Knight’s healthcare antitrust reporting in late 2025 tracked a wave of state-level attention to veterinary clinic acquisitions, including new transaction-review requirements in some states.

None of that caps what your practice is worth. It mainly changes how the larger buyers structure and time their deals, which is one more reason to have someone on your side of the table who watches this landscape full time.

The takeaway for you as a seller is a good one. More buyers, across more categories, competing more actively, is exactly the environment in which a competitive process pays off most.

What to do next

Most of what I’ve laid out here is the conversation I’d have with you over dinner in the first hour. The three buyer types, what each tends to mean for your money and your people and your name, and the honest truth that the “best” one depends entirely on what you’re trying to protect.

If you’re somewhere inside the window before you sell, the most useful thing you can do right now is get clear on your own priorities, in order. Price, staff, legacy and the name, deal structure, your post-sale role.

Rank them honestly. That ranking is what turns the abstract “who should I sell to” into a concrete buyer profile we can actually go find.

The second thing is to resist signing anything exclusive with the first buyer who makes you feel flattered, from any category. The moment you commit to one buyer before testing the others, you’ve given up the only real leverage you have, and you’ll never know what the rest of the market would have offered.

Get a Free Practice Value Estimate →

When we take on a practice, we figure out which buyers across all three categories actually fit your profile and your priorities, we build the normalized EBITDA properly, and we run the competitive process that shows you, in real offers on real terms, who your best buyer truly is. The estimate is free and there’s no obligation to go further.

Our engagement model is success-based, with no upfront fees and no retainer. We only get paid when a deal closes, and only out of the value our process delivers above what you’d have realized on your own.

---

Further reading

These are the related resources I’d point any owner toward as they work through the buyer question. Each goes deep on one piece of the decision.

• How much private equity is paying for veterinary practices — what PE-backed buyers actually pay, and the four components of any PE-backed offer.
• Veterinary practice consolidators directory — the verified directory of the major PE-backed and strategic buyers operating in 2026, with ownership and scale per buyer.
• Sell my veterinary practice — the decision-stage guide to the sale paths and what to expect at $2M-plus revenue.
• How to sell a veterinary practice — the full process from advisor engagement to closing.
• Selling your veterinary practice to NVA — a buyer-specific deep dive on one of the largest PE-backed groups.
• About Transitions Elite — the team, the methodology, and the firm’s track record.

Frequently asked questions

Who should I sell my veterinary practice to in 2026?

There are three buyer types for a veterinary practice in 2026: private equity-backed groups, strategic buyers, and individual veterinarians or small regional groups. No single type is best for everyone.

The right buyer depends on what you’re optimizing for, including price, what happens to your staff, whether your practice keeps its name, how much of the money you take as cash at close, and what role you want after the sale. The most reliable way to find the best buyer and the best price is to run a competitive process that puts qualified buyers from more than one category in front of your practice at the same time.

What is the difference between a private equity buyer and a strategic buyer for a veterinary practice?

A private equity-backed group buys practices, integrates them under shared services, and aims to sell the combined platform at a higher value in roughly 3 to 7 years. A strategic buyer acquires practices to operate them long term inside a larger company rather than to resell the platform.

In veterinary medicine the largest strategic buyer is Mars Veterinary Health, which is family-owned by Mars, Incorporated, and which owns Banfield, VCA, and BluePearl. Both are legitimate, well-capitalized buyers.

The difference is mainly their holding horizon and how they integrate the practices they buy.

Should I sell my veterinary practice to a private equity firm or to an individual veterinarian?

It depends on your size and your priorities. Practices producing roughly $1 million or more in normalized EBITDA usually draw their strongest offers from private equity-backed groups, which can pay more because they fold your earnings into a larger platform.

An individual veterinarian buyer often fits a smaller practice, an owner who wants their successor to be a single person they can mentor, or an owner who values a clean handoff to one local doctor over the highest headline number. The only way to know which path produces the better outcome for your specific practice is to test both in the same process.

Which veterinary buyer pays the most?

Directionally, private equity-backed groups and large strategic buyers pay the highest headline multiples for practices that fit their target profile, because they extract efficiencies an individual buyer cannot. Individual and small regional buyers are usually constrained by what they can finance, so they tend to pay lower headline numbers, though sometimes with simpler terms and more cash at close.

But headline rankings by category are not the same as the best offer for your practice. The buyer who pays the most is revealed deal by deal, through a competitive process, not by category in the abstract.

Will a buyer change my veterinary practice’s name and keep my staff?

It varies by buyer. Most private equity-backed groups today generally keep the local practice name, the existing team, and the day-to-day clinical culture, because the local brand is part of what they paid for.

Mars Veterinary Health, the family-owned strategic buyer, has historically moved more acquired practices onto its national brands over time. Individual buyers almost always keep the name and team because they’re buying an established, working practice.

Staff continuity and branding are negotiable points you can prioritize in a competitive process, not fixed outcomes.

What is rollover equity and which buyers ask for it?

Rollover equity means keeping a slice of ownership in the new entity after the sale instead of taking all cash at close. Private equity-backed groups commonly include some rollover or a partnership stake in their offers, because it keeps the seller invested in the practice through the hold period.

Strategic buyers and individual buyers are more likely to structure a mostly-cash purchase. Whether rollover is good for you depends on your risk tolerance and your timeline.

It’s one of the terms a competitive process lets you shop across buyers.

Can I still sell to a private buyer if I want to retire and walk away?

Yes. Most buyers in every category want some transition period, often 1 to 3 years, but the length and intensity are negotiable.

If a clean, near-complete exit is your priority, that becomes a filter you screen buyers against from the start. Some individual buyers and some strategic and private equity-backed buyers are more comfortable with a short transition than others.

Knowing your desired post-sale role before you go to market lets your advisor weight the buyer pool toward the ones who fit it.

How do I find the right buyer for my veterinary practice?

Decide what you’re optimizing for first: price, staff continuity, your legacy and the practice name, deal structure, and your post-sale role. Then run a structured competitive process that brings qualified buyers from more than one category to the table at the same time, under the same information and the same timeline.

That structure does two things at once. It surfaces which category actually fits your goals, and it produces the best price within that fit, because the buyers know they’re competing.

---

Sources

Industry M&A research and valuation data

1. Capstone Partners. “Pet Sector M&A Update — April 2026.” capstonepartners.com
2. Octus. “Private-Credit Exposure to Veterinary Rollups Shows Growing Dispersion.” 2025. octus.com
3. Mordor Intelligence. “Veterinary Medicine Market.” mordorintelligence.com

Veterinary practice ownership, profession data, and buyer landscape

4. AAHA. “Corporate consolidation and the rise of private equity.” aaha.org
5. Frontiers in Veterinary Science. “Making the case for a resurgent U.S. independent veterinary practice segment: a SWOT analysis.” 2025. frontiersin.org
6. VetPartners. “What’s New in Veterinary Practice Valuation?” vetpartners.org
7. AVMA. “AVMA data and insights on the veterinary profession.” avma.org

Public company disclosures and strategic-buyer reporting

8. Fortune. “Candy maker Mars is the biggest provider of vet care in the country.” 2024. fortune.com

Legal, regulatory, and deal-structure analysis

9. Holland & Knight. “Up Next: Vet Clinic Acquisitions Targeted for Review and Approval in New York.” 2025. hklaw.com
10. Holland & Knight. “Charting a Path Forward in 2026: Year-End Healthcare Antitrust Report.” 2025. hklaw.com
11. Dechert LLP. “Healthcare Investments Flash Alert — Latest Developments.” 2025. dechert.com